Abstract:Background: Cancer is a complex disease, caused and impacted by a combination of genetic, demographic, clinical, environmental and lifestyle factors. Analysis of cancer characteristics, risk factors, treatment options and the heterogeneity across cancer types has been the focus of medical research for years. The aim of this study is to describe and summarise genetic, clinicopathological, behavioural and demographic characteristics and their differences across ten common cancer types and evaluate their impact on overall survival outcomes. Methods: This study included data from 9977 patients with bladder, breast, colorectal, endometrial, glioma, leukaemia, lung, ovarian, prostate, and renal cancers. Genetic data collected through the 100,000 Genomes Project was linked with clinical and demographic data provided by the National Cancer Registration and Analysis Service (NCRAS), Hospital Episode Statistics (HES) and Office for National Statistics (ONS). Descriptive and Kaplan Meier survival analyses were performed to visualise similarities and differences across cancer types. Cox proportional hazards regression models were applied to identify statistically significant prognostic factor associations with overall survival. Results: 161 clinical and 124 genetic factors were evaluated for prognostic association with overall survival. Of these, 116 unique factors were found to have significant prognostic effect for overall survival across ten cancer types when adjusted for age, sex and stage. The findings confirmed prognostic associations with overall survival identified in previous studies in factors such as multimorbidity, tumour mutational burden, and mutations in genes BRAF, CDH1, NF1, NRAS, PIK3CA, PTEN, TP53. The results also identified new prognostic associations with overall survival in factors such as mental health conditions, female health-related conditions, previous hospital encounters and mutations in genes FANCE, FBXW7, GATA3, MSH6, PTPN11, RB1, RNF43. Conclusion: This study provides a comprehensive view of clinicopathological and genetic prognostic factors across different cancer types and draws attention to less commonly known factors which might help produce more precise prognosis and survival estimates. The results from this study contribute to the understanding of cancer disease and could be used by researchers to develop complex prognostic models, which in turn could help predict cancer prognosis more accurately and improve patient outcomes.

SUMMER: a Mendelian randomization interactive server to systematically evaluate the causal effects of risk factors and circulating biomarkers on pan-cancer survival

Identify Cancer Survival Related Mutation Genes from Integrated TCGA Datasets

Multi-omics Analysis to Identify Susceptibility Genes for Colorectal Cancer.

Identification of Gene Expression Pattern Related to Breast Cancer Survival Using Integrated TCGA Datasets and Genomic Tools.

Exploration of Lung Cancer-Related Genetic Factors via Mendelian Randomization Method Based on Genomic and Transcriptomic Summarized Data

DoSurvive: A webtool for investigating the prognostic power of a single or combined cancer biomarker

Assessing the Effect of Data Integration on Predictive Ability of Cancer Survival Models

A User-Friendly, Web-Based Integrative Tool (ESurv) for Survival Analysis: Development and Validation Study

Supplementary Table from A Multiethnic Germline–Somatic Association Database Deciphers Multilayered and Interconnected Genetic Mutations in Cancer

Investigating the association between genetically proxied circulating levels of immune checkpoint proteins and cancer survival: protocol for a Mendelian randomisation analysis

Exploration and Assessment of Critical Covariates of Breast Cancer Outcomes Via Between-Group Test of Survival Rates at Sir Run Run Shaw Hospital

Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer

Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancers

A three-stage approach to identify biomarker signatures for cancer genetic data with survival endpoints

Identification of Pan-Cancer Prognostic Biomarkers Through Integration of Multi-Omics Data

SurvivalMeth: a web server to investigate the effect of DNA methylation-related functional elements on prognosis

siGCD: a web server to explore survival interaction of genes, cells and drugs in human cancers

Integration of pathologic characteristics, genetic risk and lifestyle exposure for colorectal cancer survival assessment

Prognostic determinants in cancer survival: a multidimensional evaluation of clinical and genetic factors across 10 cancer types in the participants of Genomics England's 100,000 Genomes Project

CanDriS: posterior profiling of cancer-driving sites based on two-component evolutionary model